Comparison of the Effects of Omega 3 and Vitamin E on Palcitaxel-Induced Peripheral Neuropathy
- PMID: 30455762
- PMCID: PMC6236056
- DOI: 10.3889/oamjms.2018.333
Comparison of the Effects of Omega 3 and Vitamin E on Palcitaxel-Induced Peripheral Neuropathy
Abstract
Background: Paclitaxel-induced peripheral neuropathy is the most important side effect limiting the use of this medication.
Aim: This study aimed to compare the effects of omega-3 and vitamin E on the incidence of peripheral neuropathy in patients receiving Taxol.
Methods: In this clinical trial, 63 patients who were a candidate for receiving taxol, were enrolled based on inclusion and exclusion criteria. In group O, patients received 640 mg omega-3 three times a day, and group E, received 300 mg vitamin E two times a day. Patients took the supplements up to three months after the onset of Taxol. Group P received placebo for a similar period. All patients referred to a neurologist for electrophysiological evaluation before the onset of chemotherapy and at months 1 and 3. The presence of neuropathy and its progression was recorded by the neurologist.
Results: Neurological examination in this study indicated that 6 patients (28.6%) in Group O, 7 patients (33.3%) in group E, and 15 patients (71.4%) in placebo group started peripheral neuropathy. There was a significant difference between intervention groups and the placebo group (p = 0.0001) and no significant difference between intervention groups (p = 0.751).
Conclusion: Our data suggested that vitamin E and omega-3 may significantly reduce the incidence of Paclitaxel-induced peripheral neuropathy. Routine administration of such supplements that have no special side effect for patients under chemotherapy may greatly enhance their quality of life.
Keywords: Neuropathy; Omega 3; Paclitaxel; Vitamin E.
Figures
References
-
- Hagiwara HSY. Mechanism of taxane neurotoxicity. Breast Cancer. 2004;11(1):82–5. https://doi.org/10.1007/BF02968008 PMid:14718798. - PubMed
-
- Chaudhry VRE, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Annals of neurology. 1994;35(3):304–11. https://doi.org/10.1002/ana.410350310 PMid:7907208. - PubMed
-
- Kuroi KSK. Neurotoxicity of taxanes: symptoms and quality of life assessment. Breast Cancer. 2004;11(1):92–9. https://doi.org/10.1007/BF02968010 PMid:14718800. - PubMed
-
- Stillman MCJ. Management of chemotherapy-induced peripheral neuropathy. Current pain and headache reports. 2004;10(4):279–87. https://doi.org/10.1007/s11916-006-0033-z. - PubMed
-
- H S. Could n-3 polyunsaturated fatty acids reduce pathological pain by direct actions on the nervous system? Prostaglandins, leukotrienes, and essential fatty acids. 2003;68(3):219–24. https://doi.org/10.1016/S0952-3278(02)00273-9. - PubMed
LinkOut - more resources
Full Text Sources